Planmed Nuance Excel Full Field Digital Mammography (FFDM) System receives Health Canada Medical Device License
Press release
The Finnish Planmed Oy is pleased to announce that the company has received Health Canada approval for its full field digital mammography (FFDM) system Planmed Nuance Excel. The approval also includes Nuance DigiGuide digital stereotactic system.
Planmed Nuance Excel features a large 24x31 cm amorphous selenium (a-Se) detector. The unit is equipped with Planmed’s proprietary MaxView Breast Positioning System which facilitates breast positioning and helps to draw and capture more chest wall tissue into the field of view maximising the amount of visible breast tissue seen on the mammogram. The digital stereotactic biopsy system Nuance DigiGuide is the most light-weight stereotactic device available today, and it is available as an option for the whole line of Planmed FFDM products.
“We are happy to offer Canadian women our latest innovations in digital mammography,” says Mr Vesa Mattila, Vice President of Planmed Oy. “Planmed mammography units are widely used in Canada and this approval further expands our product line to cover on-going transition to digital mammography.”
Earlier Planmed has obtained Medical Device License for the Canadian market for the Planmed Nuance full field digital mammography system. Planmed Nuance and Planmed Nuance Excel units suit as well for screening as for diagnostic procedures. In addition to two detector sizes the Planmed FFDM product line is well known for its excellent image quality, low radiation dose, exquisite design and superior ergonomics.
About Planmed and the Planmeca Group
Planmed Oy develops, manufactures, and markets advanced imaging equipment and accessories allowing early detection of breast cancer. The product range covers digital and analogue mammography units, mobile mammography units, stereotactic biopsy devices, and breast positioning systems.
Planmed Oy exports more than 98% of its mammography equipment to over 70 countries worldwide. The principal markets are Europe, Japan, Oceania as well as North and Latin America where the company has considerable market shares. Planmed Oy is part of the Finland-based Planmeca Group that manufactures and markets advanced products for the medical and the dental field. The Group currently employs approximately 2,300 people worldwide and expects a turnover of EUR 600 million in 2009.
www.planmed.com